DK0618808T3 - Farmaceutiske præparater der indeholder gonadotropin med saccharosestabilisator - Google Patents

Farmaceutiske præparater der indeholder gonadotropin med saccharosestabilisator

Info

Publication number
DK0618808T3
DK0618808T3 DK93901557T DK93901557T DK0618808T3 DK 0618808 T3 DK0618808 T3 DK 0618808T3 DK 93901557 T DK93901557 T DK 93901557T DK 93901557 T DK93901557 T DK 93901557T DK 0618808 T3 DK0618808 T3 DK 0618808T3
Authority
DK
Denmark
Prior art keywords
pct
pharmaceuticals containing
sucrose
containing gonadotropin
sec
Prior art date
Application number
DK93901557T
Other languages
Danish (da)
English (en)
Inventor
Fabrizio Samaritani
Patrizia Natale
Original Assignee
Applied Research Systems
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Applied Research Systems filed Critical Applied Research Systems
Application granted granted Critical
Publication of DK0618808T3 publication Critical patent/DK0618808T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22Hormones
    • A61K38/24Follicle-stimulating hormone [FSH]; Chorionic gonadotropins, e.g. HCG; Luteinising hormone [LH]; Thyroid-stimulating hormone [TSH]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/06Drugs for disorders of the endocrine system of the anterior pituitary hormones, e.g. TSH, ACTH, FSH, LH, PRL, GH

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Reproductive Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
DK93901557T 1991-12-18 1992-12-17 Farmaceutiske præparater der indeholder gonadotropin med saccharosestabilisator DK0618808T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ITRM910952A IT1250075B (it) 1991-12-18 1991-12-18 Composizioni farmaceutiche contenenti gonadotropine.
PCT/IT1992/000165 WO1993011788A1 (en) 1991-12-18 1992-12-17 Gonadotropin containing pharmaceutical compositions with sucrose stabilizer

Publications (1)

Publication Number Publication Date
DK0618808T3 true DK0618808T3 (da) 2000-05-15

Family

ID=11400511

Family Applications (1)

Application Number Title Priority Date Filing Date
DK93901557T DK0618808T3 (da) 1991-12-18 1992-12-17 Farmaceutiske præparater der indeholder gonadotropin med saccharosestabilisator

Country Status (13)

Country Link
US (1) US5650390A (el)
EP (1) EP0618808B1 (el)
JP (1) JP3702313B2 (el)
AT (1) ATE189608T1 (el)
AU (1) AU677773B2 (el)
CA (1) CA2124801C (el)
DE (1) DE69230672T2 (el)
DK (1) DK0618808T3 (el)
ES (1) ES2142860T3 (el)
GR (1) GR3033276T3 (el)
IT (1) IT1250075B (el)
PT (1) PT618808E (el)
WO (1) WO1993011788A1 (el)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5828979A (en) * 1994-09-01 1998-10-27 Harris Corporation Automatic train control system and method
DE69524456T2 (de) * 1995-03-21 2002-08-01 Applied Research Systems Flüssige hcg-formulierungen
US6319504B1 (en) 1996-06-24 2001-11-20 University Of Maryland Biotechnology Institute Treatment and prevention of HIV infection by administration of derivatives of human chorionic gonadotropin
IT1284876B1 (it) 1996-08-07 1998-05-22 Applied Research Systems Hcg come inibitore della collagenasi
IL122732A0 (en) * 1997-01-15 1998-08-16 Akzo Nobel Nv Liquid gonadotropin-containing formulation its preparation and a device containing same
BR9912243A (pt) * 1998-07-23 2001-10-16 Lilly Co Eli Formulações de fsh e variantes de fsh, produtos e processos
US20030166525A1 (en) * 1998-07-23 2003-09-04 Hoffmann James Arthur FSH Formulation
US7112341B1 (en) 1999-04-13 2006-09-26 Nektar Therapeutics Pulmonary administration of dry powder formulations for treating infertility
ATE356138T1 (de) * 2000-02-22 2007-03-15 Applied Research Systems Gereinigtes recombinantes hlh mit spezifischer bioaktivität und verfahren zu dessen reinigung
JP4588960B2 (ja) * 2000-02-22 2010-12-01 メルク セローノ ソシエテ アノニム hCGの精製方法及び本法により精製した組換えhCG
GB0121709D0 (en) * 2001-09-07 2001-10-31 Imp College Innovations Ltd Food inhibition agent
PL205472B1 (pl) * 2001-09-12 2010-04-30 Serono Lab Zastosowanie hormonu luteinizującego (LH)
NZ535008A (en) * 2002-02-08 2005-09-30 Alkermes Inc Polymer-based compositions for sustained release
AR043972A1 (es) * 2003-04-02 2005-08-17 Ares Trading Sa Formulaciones farmaceuticas de fsh y lh
PT1638595E (pt) 2003-06-20 2013-04-26 Ares Trading Sa Fsh liofilizada / formulações de hl
KR101105871B1 (ko) * 2005-09-27 2012-01-16 주식회사 엘지생명과학 인 난포자극호르몬의 안정한 용액 제형
MX2010004639A (es) * 2007-11-01 2010-08-04 Merck Serono Sa Formulaciones liquidas de hormona luteinizante (lh).
CN101269215B (zh) * 2008-05-15 2011-03-23 上海天伟生物制药有限公司 一种糖蛋白激素组合物
CN102309747B (zh) * 2008-09-17 2013-04-17 上海天伟生物制药有限公司 高纯度绝经期促性腺素冻干针剂
KR101483165B1 (ko) * 2009-12-22 2015-01-15 샹하이 테크웰 바이오파마슈티컬 컴퍼니, 리미티드 인간폐경성선자극호르몬의 조성물
JP6426410B2 (ja) * 2013-09-11 2018-11-21 第一三共株式会社 室温保存用凍結乾燥製剤

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3637640A (en) * 1970-05-04 1972-01-25 Diagnostic Data Inc Orgotein stabilized with saccharide process and products
US3816617A (en) * 1972-07-25 1974-06-11 American Home Prod Method for inducing menses
DD141996A1 (de) * 1979-02-21 1980-06-04 Ingrid Wolf Verfahren zur herstellung von lyophilisierten lhrh-praeparationen
JPS59109862A (ja) * 1982-12-15 1984-06-25 Takeda Chem Ind Ltd 凍結乾燥感作血球の製造法
WO1985001959A1 (en) * 1983-11-02 1985-05-09 Integrated Genetics, Inc. Production of heterodimeric human fertlity hormones
JPS60258125A (ja) * 1984-06-06 1985-12-20 Hayashibara Biochem Lab Inc 蛋白性生理活性物質を含有する水溶性乾燥物
IT1206302B (it) * 1987-06-26 1989-04-14 Serono Cesare Ist Ricerca Ormone follicolo-stimolante urinario
US5215743A (en) * 1988-04-13 1993-06-01 Maninder Singh Tumor necrosis factor formulations
EP0411033B1 (en) * 1988-04-29 1994-09-07 Genetics Institute, Inc. Storage stable formulations of homogenous dimeric m-csf
JPH02121933A (ja) * 1988-10-28 1990-05-09 Kagaku Shiryo Kenkyusho:Kk 動物用油性ホルモン顆粒剤
US5087615A (en) * 1989-03-17 1992-02-11 Applied Research Systems Ars Holding N.V. Novel method of ovulation induction in humans
IE64738B1 (en) * 1990-03-20 1995-09-06 Akzo Nv Stabilized gonadotropin containing preparations

Also Published As

Publication number Publication date
WO1993011788A1 (en) 1993-06-24
ES2142860T3 (es) 2000-05-01
DE69230672D1 (de) 2000-03-16
CA2124801C (en) 2007-08-07
AU677773B2 (en) 1997-05-08
ITRM910952A0 (it) 1991-12-18
ITRM910952A1 (it) 1993-06-18
JP3702313B2 (ja) 2005-10-05
AU3266293A (en) 1993-07-19
JPH07507047A (ja) 1995-08-03
US5650390A (en) 1997-07-22
PT618808E (pt) 2000-07-31
IT1250075B (it) 1995-03-30
EP0618808A1 (en) 1994-10-12
GR3033276T3 (en) 2000-09-29
DE69230672T2 (de) 2000-09-21
CA2124801A1 (en) 1993-06-24
ATE189608T1 (de) 2000-02-15
EP0618808B1 (en) 2000-02-09

Similar Documents

Publication Publication Date Title
DK0618808T3 (da) Farmaceutiske præparater der indeholder gonadotropin med saccharosestabilisator
IL112112A0 (en) Peptide derivatives and pharmaceutical compositions containing them
ES2057731T3 (es) Preparaciones que contienen gonadotropinas estabilizadas.
NO905472L (no) Insulinanaloger fra menneske og blandinger som inneholderdem.
EP0346429A4 (en) Peptide analogues of insulin-like growth factor 1 (igf-1) or factor 2 (igf-2)
ATE230277T1 (de) Stabilisierte antikörperformulierung
HUT74269A (en) Stable lyophilized pharmaceutical preparations of g-csf
KR940703689A (ko) 성장호르몬과 아스파라진으로 이루어지는 안정화된 약학제제(a stabil-ized pharmaceutical formulation comprising growth gormone and asparagine)
SE8703938L (sv) Peptidderivat
NO941186D0 (no) Hormonanaloger med multiple CTP-forlengelser
MX9703550A (es) Secretagogos de hormona del crecimiento, peptidomimeticos, de bajo peso molecular.
NO952321L (no) Polypeptid, samt anti-HIV-preparat fremstilt fra dette
HUP0002704A2 (hu) Az 5. és a 6. helyzetben módosított GnRH antagonisták
DK0804223T3 (da) Farmaceutiske præparater indeholdende hGH
GR3024708T3 (en) Pharmaceutical compositions containing il-6.
NZ336793A (en) Method for stabilizing peptides by adding an organic acid and then lyophilizing the peptide mixture
DK1074264T3 (da) Inhibitorer for neovaskularisering
KR890012960A (ko) 결정성 β-락탐 용매화물
DK0441106T3 (da) Thyoxin til genopbygning af neuronal plasticitet
NO20006022L (no) Rekombinant human interferon <beta>-1A (IFN-<beta>-1A)- formulering
ATE149354T1 (de) Pharmazeutische zusammensetzung von stabilisiertem (leu 13>-motilin-hse
Jöchle Influence of prostaglandin F autoantibodies on the estrous cycle of the guinea pig: Hildebrandt-Stark, HE, GJ Marcus, K. Yoshinaga, HR Behrman and RO Greep: Prostaglandins 9: 231, 1975. Lab. of Human Reprod. & Reprod. Biol., Dept. Anatomy, Harvard Medical School, Boston, Massachusetts 02115
DK661888A (da) Biologisk aktive molekyler
IT1241459B (it) Composizioni farmaceutiche per la somministrazione rettale di calcitonina
NO950114L (no) Amylin-antagonister og agonister